Spots Global Cancer Trial Database for methoxyamine
Every month we try and update this database with for methoxyamine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors | NCT00892385 | Unspecified Adu... | Methoxyamine Temozolomide | 18 Years - | Case Comprehensive Cancer Center | |
| Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer | NCT02535325 | Locally Advance... Stage III Lung ... Stage III Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIA Lung... Stage IIIA Lung... Stage IIIB Lung... Stage IIIB Lung... Stage IIIB Lung... Stage IV Lung A... Stage IV Lung L... Stage IV Lung N... | 3-Dimensional C... Cisplatin Intensity-Modul... Methoxyamine Methoxyamine Hy... Pemetrexed Pemetrexed Diso... | 18 Years - | National Cancer Institute (NCI) | |
| Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer | NCT02535325 | Locally Advance... Stage III Lung ... Stage III Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIA Lung... Stage IIIA Lung... Stage IIIB Lung... Stage IIIB Lung... Stage IIIB Lung... Stage IV Lung A... Stage IV Lung L... Stage IV Lung N... | 3-Dimensional C... Cisplatin Intensity-Modul... Methoxyamine Methoxyamine Hy... Pemetrexed Pemetrexed Diso... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer | NCT05198830 | Lung Adenocarci... Lung Large Cell... Lung Non-Squamo... Stage III Lung ... | Carboplatin Cisplatin Computed Tomogr... Durvalumab Magnetic Resona... Methoxyamine Pemetrexed Positron Emissi... Radiation Thera... | 18 Years - | National Cancer Institute (NCI) | |
| Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma | NCT02395692 | Adult Brain Gli... | Treatment Methoxyamine Temozolomide | 18 Years - | National Cancer Institute (NCI) | |
| Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma | NCT02395692 | Adult Brain Gli... | Treatment Methoxyamine Temozolomide | 18 Years - | National Cancer Institute (NCI) | |
| Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin | NCT02535312 | Advanced Malign... Advanced Perito... Advanced Pleura... Recurrent Perit... Recurrent Pleur... Refractory Mali... Unresectable So... | Cisplatin Methoxyamine Pemetrexed Diso... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
